Angiosarcoma of the thyroid in an old man
© Petronella et al; licensee BioMed Central Ltd. 2011
Published: 24 August 2011
The angiosarcoma of the thyroid gland is a primary malignant highly aggressive tumor. It is classified as a malignant vascular thyroid lesion of mesenchymal origin. In addition to the neck and head, the majority of angiosarcomas also originate from the skin and soft tissues, or limbs of patients with lymphedema.
Angiosarcoma of the thyroid is rare and the greatest incidence is witnessed near the Alps. It constitutes only 2-10% of malignant thyroid tumors in Switzerland, Austria and Northern Italy.
The prevalence in the Alpine regions can be due probably to iodine deficiency with a long history of endemic goiter. It strikes in old age. There are cases in which the tumor occurs without a history of goiter, and it the occurrence is very unusual in non-alpine areas, so it seemed interesting to present a case involving this type.
Due to the increase of the thyroid volume, often occurring in a short time, dyspnea is a frequent symptom, associated with deviation of the tracheal axis.
From the macroscopic point of view, this tumor typically appears to be with big dimensions, with large areas of necrosis and hemorrhage. Microscopically, freely anastomosed channels are often associated with a papillary configuration having a pattern of predominant intraluminal growth; the nuclei of the epithelioid endothelial cells are large, vesicular, smooth-contoured, with a large basophilic or amphophylic nucleolus connected by chromatin strands to the nuclear membrane. Typical and atypical mitosis were found in large numbers; the growth pattern is usually highly invasive and tumor necrosis is very strong. Of fundamental importance is the peculiarity that tumor cells express vascular markers such as Factor VIII, CD 31 and CD 34.
The distinction between angiosarcoma and anaplastic sarcomatoid carcinoma is difficult and the same expression of the angiosarcoma has been subject to dispute.
Clinical history: most of these tumors appear as a poorly encapsulated and infiltrating mass, which tends to grow in the absence of pain. Local recurrence, even after complete excision, and metastasis are common.
After diagnosis, patients often die quickly. This type of cancer typically metastasizes in the first instance at the level of regional lymph nodes and lung, in the late stages in the bone marrow. Multimodal treatment, a widely accepted approach, envisages surgery, radiotherapy and chemotherapy.
The study was inspired by the observation of a case of thyroid hemangiosarcoma in a 71-year-old man with a history of goiter for twenty years, who decided to undergo an operation for the worsening of the dyspnea.
A 71-year-old male came to our department complaining of dyspnea, hypoventilation and dysphonia, determined by swelling in the neck region, related to considerable increase of the thyroid gland.
On examination, the thyroid gland also appeared fairly static during the acts of deglutition. With this pathology, the patient had been living for more than twenty years, without any type of therapy.
An ultrasound examination dating back to 1997, documented a complete subversion of the echotexture of the whole gland and the presence of a large nodule in the right lobe displaying a complex echotexture. A further ecography in the year 2000 documented the increase in volume of the thyroid which was also the cause of the right carotid bulb dislocation.
Among the laboratory tests, we also found significantly elevated thyroglobulin values. The preoperative FNAC was not significant and we decided to not repeat it for the necessary surgical indication due to worsening dyspnea.
Neck and chest CT was performed without contrast from which was noticed, in the right lobe of the thyroid, a voluminous expansive formation characterized by a hyperdense rim surrounding large areas of liquid hypodensity and the presence of lymph node nodules in the right submandibular region. Also the left lobe of the thyroid appeared increased in size with hypodense nodular formations of colloid cyst type. It also showed a small nodular formation, of about 3mm in size, of dubious diagnostic ascription, in the posterior basal segment of the right lower lobe of the lung.
Although surgical operation was expected to be very complex, it was performed in a completely linear way. The left lobe was easily separable from the surrounding tissue; it appeared in the throes of a nodular transformation and was immersed. The right lobe appeared uniformly in the throes of nodular and colloid cyst transformation and penetrated the upper part of the neck, adhering to the vessels, from which, however, it was easily dissociated; it measured about 15 cm. Lymph nodes were not visible. Surgical times were also lower than expected, particularly the removal of the right half was relatively easy and the mass appeared well encapsulated and demarcated.
Histo-citopathological analysis revealed for the right lobe a nodule composed of necrotic hemorrhagic areas surrounded by a fibrous capsule within which there were anastomosing channels bordered by atypical epithelioid cells. The positivity for CD31 and factor VIII and the negativity for CK deposed for the diagnosis of thyroid angiosarcoma.
Our case’s peculiarities are represented by the patient’s lack of provenance from an Alpine area and by the absence of rapid growth, behavior that diverges from most of the cases described in literature. Diagnosing the angiosarcoma is not easy even on a histological examination, and it must be supported by detailed investigations (positivity for CD31 and factor VIII, negativity for CK). Immunohistochemical markers of endothelial differentiation and the demonstration of Weibel-Palade bodies at ultrastructural level support the idea that the origin of this tumor is endothelial. Cytocheratine expression and morphological mimicry of epithelioid angiosarcoma with anaplastic carcinoma highlight the importance of using a broad panel of immunostains in the diagnostic workup of these tumors, in conjunction with a careful microscopic and ultrastructural study. CD31 is considered the most sensitive and specific marker for endothelial differentiation, being expressed in 90% of angiosarcomas and in slightly more than 1% of carcinomas; the endothelial marker CD34 and the antigen related to factor VIII should be added to the panel too.
A hypothesis that derives from our observation concerns the role of thyroglobulin testing; there are not many studies that evaluate the correlation with the angiosarcoma, so further work can be envisaged.
- Seng G, Nicholas G, MBBS, Khoon LC, FRCPA, Hood K, Christopher G, Yun Y Cosmas C FRCS(Edin): Two Cases of Epithelioid Angiosarcoma Involving the Thyroid and a Brief Review of Non-Alpine Epithelioid Angiosarcoma of the Thyroid. Arch Pathol Lab Med. 2003, 127: 71-73.Google Scholar
- Yilmazlar T, Kirdak T, Adim S, Ozturk E, Yerci O: A case of hemangiosarcoma in thyroid with severe anemia due to bone marrow metastasis. Endocr J. 2005, 52 (1): 57-9. 10.1507/endocrj.52.57.View ArticlePubMedGoogle Scholar
- Eusebi V, Carcangiu ML, Dina R, Rosai J: Keratin-positive epithelioid angiosarcoma of the thyroid: a report of four cases. Am J Surg Pathol. 1990, 14: 737-747. 10.1097/00000478-199008000-00004.View ArticlePubMedGoogle Scholar
- Kalitova P, Plzak J, Kodet R, Astl J: Angiosarcoma of the thyroid. Eur Arch Otorhinolaryngol. 2009, 266 (6): 903-5. 10.1007/s00405-008-0820-8.View ArticlePubMedGoogle Scholar
- Cutlan RT, Greer JE, Wong FS, Eltorky M: Immunohistochemicel characterization of thyroid gland tumors. Exp Mol Pathol. 2000, 69: 159-164. 10.1006/exmp.2000.2323.View ArticlePubMedGoogle Scholar
- Del Rio P, Cataldo S, Sommaruga L, Corcione L, Guazzi A, Sianesi M: A rare case of thyroid haemangiosarcoma. Chir Ital. 2007, 59: 747-749.PubMedGoogle Scholar
- Papotti M, Arrondini M, Tavaglione V, Veltri A, Volante M: Diagnostic controversies in vascular proliferations of the thyroid gland. Endocr Pathol. 2008, 19 (3): 175-83. 10.1007/s12022-008-9039-x.View ArticlePubMedGoogle Scholar
- Lin O, Gerhard R, Coelho Siqueira SA: Cytologic findings of epithelioid angiosarcoma of the thyroid. A case report. Acta Cytol. 2002, 46: 767-771. 10.1159/000326994.View ArticlePubMedGoogle Scholar
- Hassan I, Barth P, Celik I, HoVmann S, Langer P, Ramaswamy A, Wagner HJ, Rothmund M, Zielke A: An authentic malignant epithelioid hemangioendothelioma of the thyroid: a case report and review of the literature. Thyroid. 2005, 15: 1377-1381. 10.1089/thy.2005.15.1377.View ArticlePubMedGoogle Scholar
- Sniezek JC, Holten M: Rare tumors of the thyroid gland. Otolaryngol Clin NAm. 2003, 36: 107-115. 10.1016/S0030-6665(02)00134-2.View ArticleGoogle Scholar
- Ritter JH, Mills SE, Nappi O, Wick MR: Angiosarcoma-like neoplasms of epithelial organs: true endothelial tumors or variants of carcinoma?. Semin Diagn Pathol. 1995, 12: 270-82.PubMedGoogle Scholar
- Banerjee SS, Eyden BP, Wells S, McWilliam LJ, Harris M: Pseudoangiosarcomatous carcinoma: A clinicopathological study of seven cases. Histopathology. 1992, 21: 13-23.View ArticlePubMedGoogle Scholar
- Isa NM, James DT, Saw TH, Pennisi R, Gough I: Primary angiosarcoma of the thyroid gland with recurrence diagnosed by fine needle aspiration: a case report. Diagn Cytopathol. 2009, 37 (6): 427-32. 10.1002/dc.21065.View ArticlePubMedGoogle Scholar
- Goh SG, Chuah KL, Goh HK, Chen YY: Two cases of epithelioid angiosarcoma involving the thyroid and a brief review of non-Alpine epithelioid angiosarcoma of the thyroid. Arch Pathol Lab Med. 2003, 127: 70-73.Google Scholar
- Ain KB: Unusual types of thyroid cancer. Rev Endocr Metab Disord. 2000, 1: 225-231. 10.1023/A:1010039317050.View ArticlePubMedGoogle Scholar
- Astl J, Duskova J, Limanova Z, Povysil C, Kuchynkova Z: Hemangiosarcoma of the thyroid gland. A case report. Neuro Endocrinol Lett. 2000, 21: 213-216.PubMedGoogle Scholar
- Maiorana A, Collina G, Cesinaro AM, Fano RA, Eusebi V: Angiomatoid carcinoma of the thyroid: clinicopathological analysis of seven cases from non-Alpine areas. Virchows Arch. 1996, 429: 131-137.PubMedGoogle Scholar
- Papotti M, Volante M, Negro F, Eusebi V, Bussolati G: Thyroglobulin mRNA expression helps to distinguish anaplastic carcinoma from angiosarcoma of the thyroid. Virchows Arch. 2000, 437 (6): 635-42. 10.1007/s004280000308.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.